BML Investment Partners, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value (ACRS)

Filing Manager: BML Investment Partners, L.P.
Reporting Manager: BML Investment Partners, L.P.
Security: Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value
Symbol: ACRS
Shares outstanding: 107,142,857 shares
Disclosed Ownership: 14,250,000 shares
Ownership: 13.3%
Form type: SCHEDULE 13G/A
Filing time: 13 Feb 2025, 14:26:40 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BML Investment Partners, L.P.	13.3%	14,250,000	0	14,250,000	Braden M Leonard	BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member